Papers
23
Total Citations
2,230
H-Index
16
About
Daniel A. Barocas is a prominent urologic oncologist whose research has fundamentally shaped our understanding of minimally invasive surgical approaches for urological cancers, particularly bladder and prostate cancer. He is best known as a key investigator in the landmark RAZOR trial — a randomized, phase 3 study comparing robot-assisted versus open radical cystectomy in bladder cancer patients — which has accumulated over 760 citations since its 2018 publication and established the non-inferiority of the robotic approach for oncological outcomes. His follow-up RAZOR analysis at three years further confirmed the durability of these findings, cementing robotic cystectomy as a viable surgical standard. Beyond bladder cancer, Barocas has made significant contributions to prostate cancer surgery, examining biochemical recurrence, transfusion requirements, complication profiles, and functional outcomes comparing robotic-assisted laparoscopic prostatectomy to traditional open approaches across large institutional and population-based cohorts. His work on salvage robotic prostatectomy represents one of the largest single-institution series on this challenging procedure. With contributions to health economic modeling and real-world population data, Barocas consistently bridges clinical rigor with practical impact, helping surgeons and patients make more informed treatment decisions. His cumulative citation record reflects a body of work that has genuinely moved the field forward.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10